Norris Medicines Limited (BOM:524414)

Market Cap	179.91M
Revenue (ttm)	58.20M
Net Income (ttm)	-12.38M
Shares Out	10.00M
EPS (ttm)	-1.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,455
Average Volume	986
Open	16.26
Previous Close	17.08
Day's Range	16.26 - 17.93
52-Week Range	12.57 - 27.74
Beta	-0.25
RSI	46.41
Earnings Date	Aug 8, 2025

About Norris Medicines

Norris Medicines Limited primarily engages in the manufacture of pharmaceutical formulations in India. It offers products in the fields of antibiotic, anti-inflammatory-pain management, analgesic, gastrointestinal, dermatological, nutrition, anti-malarial, anti-emetic, cough/cold, dental, diabetic, and cardiac, as well as other fields in various formulations, including tablets, capsules, liquid orals, and copical ointments. The company also offers contract and loan license manufacturing services. In addition, it exports its products to European...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 45
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524414

Financial Performance

In 2024, Norris Medicines's revenue was 58.20 million, an increase of 3.28% compared to the previous year's 56.36 million. Losses were -12.38 million, 4.28% more than in 2023.